In vivo emergence of aspergillus terreus with reduced azole susceptibility and a Cyp51a M217I Alteration

Journal of Infectious Diseases

Volumn 206, Issue 6, 2012, Pages 981-985

  Arendrup, Maiken C ^a   Jensen, Rasmus H ^a   Grif, Katharina ^d   Skov, Marianne ^b   Pressler, Tacjana ^b   Johansen, Helle K ^c   Lass Flörl, Cornelia ^d  

^a STATENS SERUM INSTITUT   (Denmark)

^b Department of Paediatrics   (Denmark)

^c Rigshospitalet   (Denmark)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; POSACONAZOLE; STEROL 14ALPHA DEMETHYLASE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS TERREUS; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYP51A GENE; CYSTIC FIBROSIS; DNA SEQUENCE; FUNGUS ISOLATION; GENE; GENE MUTATION; GENETIC IDENTIFICATION; GENOTYPE; HUMAN; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANTIFUNGAL AGENTS; ASPERGILLUS; AZOLES; CYTOCHROME P-450 ENZYME SYSTEM; DNA, FUNGAL; DRUG RESISTANCE, MULTIPLE, FUNGAL; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; GENOTYPE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MUTATION;

EID: 84862606349     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis442     Document Type: Article

References (15)

1. Mortensen KL, Jensen RH, Johansen HK, et al. Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance. J Clin Microbiol 2011; 49:2243-51.
2. Denning DW, Venkateswarlu K, Oakley KL, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997; 41:1364-8.
3. Howard SJ, Cerar D, Anderson MJ, et al. Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerging Infectious Diseases 2009; 15:1068-76.
4. Howard SJ, Arendrup MC. Acquired antifungal drug resistance in Aspergillus fumigatus: epidemiology and detection. Med Mycol 2011; 49 (Suppl 1):S90-5.
5. Camps SMT, van der Linden JWM, Li Y, et al. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrobial Agents and Chemotherapy 2012; 56:10-6.
6. Snelders E, van der Lee HA, Kuijpers J, et al. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med 2008; 5:e219.
7. Mortensen KL, Mellado E, Lass-Florl C, Rodriguez-Tudela JL, Johansen HK, Arendrup MC. Environmental study of azole-resistant Aspergillus fumigatus and Other aspergilli in Austria, Denmark, and Spain. Antimicrobial Agents and Chemotherapy 2010; 54:4545-9.
8. Gomez-Lopez A, Garcia-Effron G, Mellado E, Monzon A, Rodriguez-Tudela JL, Cuenca-Estrella M. In vitro activities of three licensed antifungal agents against Spanish clinical isolates of Aspergillus spp. Antimicrobial Agents and Chemotherapy 2003; 47:3085-8.
9. Pfaller MA, Duncanson F, Messer SA, Moet GJ, Jones RN, Castanheira M. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods. Antimicrobial Agents and Chemotherapy 2011; 55:5155-8.
10. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee forAntimicrobial Susceptibility Testing (EUCAST). EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. EUCAST 2008; 14:982-4.
11. Blum G, Perkhofer S, Grif K, et al. A 1-year Aspergillus terreus surveillance study at the university hospital of Innsbruck: molecular typing of environmental and clinical isolates. Clinical Microbiology and Infection 2008; 14:1146-51.
12. Bueid A, Howard SJ, Moore CB, et al. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. Journal of Antimicrobial Chemotherapy 2010; 65:2116-8.
13. Arendrup MC, Mavridou E, Mortensen KL, et al. Development of azole resistance in Aspergillus fumigatus during azole therapy associated with change in virulence. PLoS ONE 2010; 5:e10080.
14. Rajendran R, Mowat E, McCulloch E, et al. Azole resistance of Aspergillus fumigatus biofilms is partly associated with efflux pump activity. Antimicrobial Agents and Chemotherapy 2011; 55:2092-7.
15. Nascimento AM, Goldman GH, Park S, et al. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrobial Agents and Chemotherapy 2003; 47:1719-26.